Form D · Venture Capital Fund
AVSF - Beacon Biosignals 2026, LLC
Boston, MA · CIK 0002141770
Offering snapshot reported Oct 13, 2026 · SEC filing
- Reported sold
- $894K Indefinite offering
- Investors reported
- 59 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Sep 18, 2026 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$541,000 → $893,500
- Reported investors41 → 59
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2026 | Amendment | $893,500 | $352,500vs Oct 2, 2026 | 59 | SEC filing |
| Oct 2, 2026 | Initial | $541,000 | No comparison | 41 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-599818
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Collins | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Boston, MA, 02110